Albany, NY -- (SBWIRE) -- 10/30/2019 -- Crohn's Disease Market Insights, Epidemiology and Market Forecast-2028

1. About 1.4 million Americans have Crohn's disease or ulcerative colitis.
2. Of those, about 780,000 have Crohn's Disease.
3. Crohn's Disease can occur at any age and is more prevalent among adolescents and young adults between the ages of 15 and 35.

(Albany, US) DelveInsight launched a new report on Crohn's Disease Market Insights, Epidemiology and Market Forecast-2028

Key benefits

1. Crohn's Disease market report covers a descriptive overview and comprehensive insight of the Crohn's Disease epidemiology and Crohn's Disease market in the 7 MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)
2. Crohn's Disease market report provides insights into current and emerging therapies.
3. Crohn's Disease market report provides a global historical and forecasted market covering drug outreach in 7 MM.
4. Crohn's Disease market report offers an edge that will help in developing business strategies by understanding trends shaping and leading the Crohn's Disease market.

Request for sample pages

"In the years between 1992 and 2004, there was a 74% increase to doctor's office visits due to Crohn's disease."

Crohn's disease is an inflammatory bowel disease that causes inflammation in the digestive tract, which can lead to abdominal pain, severe diarrhea, fatigue, weight loss and malnutrition among the affected individuals. It is also worth mentioning here that the Inflammation caused by Crohn's disease can involve different areas of the digestive tract in different people. The current strategies for the Crohn's Disease treatment primarily focus on the reduction of the Crohn's Disease symptoms by reducing bowel inflammation with the utter aim of making patients clinically comfortable. In general, the mainstays for the Crohn's disease treatment includes drug therapies and surgical procedures in some cases. The current Crohn's Disease market is being driven by these therapies and procedures.

The standardized approved evidence-based therapies for the Crohn's Disease treatment includes infliximab (Remicade), adalimumab (Humira), certolizumab pegol (Cimzia), Natalizumab (Tysabri), vedolizumab (Entyvio), Ustekinumab (Janessan)). The Crohn's Disease therapies have been approved for moderate to severe issues.
The other factors that shall further fuel the growth of Crohn's Disease market include increased understanding about the disease, introduction of novel therapies in the Crohn's Disease market, and other innovative Crohn's Disease treatment options to overcome the limitation of current Crohn's Disease treatment regimen and improved patient-of-care. These all will contribute toward the Crohn's Disease market growth during the forecast period (2019-2028).

The launch of the emerging therapies is expected to significantly impact Crohn's Disease treatment scenario in the upcoming years: -
Drugs covered
1. Filgotinib
2. Risankizumab
3. Etrolizumab
And many others

The key players in Crohn's Disease market are:
1. Gilead Sciences
2. Celgene Corporation
3. Abbvie
4. Genetech
And many others

Table of contents

1. Report Introduction
2. Crohn's Disease Market Overview at a Glance
3. Crohn's Disease Disease Background and Overview
4. Crohn's Disease Epidemiology and Patient Population
5. Crohn's Disease Country- Wise Epidemiology
5.1. United States
5.2. EU-5
5.2.1 France
5.2.2. Germany
5.2.3 Spain
5.2.4 Italy
5.2.5 United Kingdom
5.3. Japan
2. Crohn's Disease Treatments & Medical Practices
3. Crohn's Disease Marketed Products
3.1. CIMZIA (certolizumab pegol): UCB
3.2. ENTYVIO (vedolizumab): Millennium Pharmaceuticals
4. Crohn's Disease Emerging Therapies
4.1. Key Cross Competition
4.2. Filgotinib : Gilead Sciences
4.3. Risankizumab: Abbvie
4.4. Etrolizumab: Genetech
5. Crohn's Disease Market Size
6. Crohn's Disease 7MM Country-Wise Market Analysis
6.1. United States Market Size
6.2. Germany Market Size
6.3. France Market Size
6.4. United Kingdom Market Size
6.5. Spain Market Size
6.6. Italy Market Size
6.7. Japan Market Size
7. Market Drivers
8. Market Barriers
9. Crohn's Disease Report Methodology
10. DelveInsight Capabilities
11. Disclaimer
12. About DelveInsight

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end to end comprehensive solutions to improve their performance.

Contact us:
Shruti Thakur
info@delveinsight.com
+919650213330
SOURCE DelveInsight